Emtricitabine/tenofovir disoproxil fumarateHypophosphataemia, fanconi syndrome and bone disorders: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1509卷 / 1期

关键词：

D O I：

10.1007/s40278-014-1837-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[31] Emtricitabine/tenofovir disoproxil fumarateRenal impairment: case report
[J]. Reactions Weekly, 2022, 1937 (1) : 210 - 210
[32] Emtricitabine/tenofovir disoproxil fumarateRenal impairment: case report
[J]. Reactions Weekly, 2018, 1703 (1) : 106 - 106
[33] Emtricitabine/tenofovir disoproxil fumarateInterstitial nephritis: case report
[J]. Reactions Weekly, 2011, 1367 (1) : 18 - 18
[34] Emtricitabine/tenofovir disoproxil fumarateSevere hypokalaemia: case report
[J]. Reactions Weekly, 2008, 1208 (1) : 12 - 12
[35] Emtricitabine/tenofovir disoproxil fumarateToxic neuropathy: case report
[J]. Reactions Weekly, 2014, 1483 (1) : 42 - 42
[36] Emtricitabine/tenofovir disoproxil fumarateTreatment failure: case report
[J]. Reactions Weekly, 2022, 1887 (1) : 297 - 297
[37] Emtricitabine/tenofovir disoproxil fumarateDrug resistance: case report
[J]. Reactions Weekly, 2018, 1731 (1) : 107 - 107
[38] Emtricitabine/tenofovir disoproxil fumarateSkin rash: case report
[J]. Reactions Weekly, 2018, 1703 (1) : 107 - 107
[39] Emtricitabine/tenofovir disoproxil fumarateRenal dysfunction: case report
[J]. Reactions Weekly, 2016, 1618 (1) : 77 - 77
[40] Emtricitabine/tenofovir disoproxil fumarateDrug hypersensitivity: case report
[J]. Reactions Weekly, 2007, 1177 (1) : 13 - 13

← 1 2 3 4 5 →